USANA Health Sciences, Inc.
USNA
$16.92
-$0.22-1.28%
NYSE
| 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.76M | 16.99M | 34.12M | 34.90M | 42.03M |
| Total Depreciation and Amortization | 39.70M | 35.30M | 31.29M | 27.39M | 22.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.97M | 9.64M | 8.49M | 7.52M | 9.74M |
| Change in Net Operating Assets | -43.08M | -30.41M | -10.88M | -11.01M | -13.00M |
| Cash from Operations | 22.35M | 31.52M | 63.02M | 58.79M | 60.99M |
| Capital Expenditure | -13.82M | -12.83M | -12.03M | -9.68M | -10.07M |
| Sale of Property, Plant, and Equipment | 3.91M | 0.00 | 61.00K | 61.00K | 64.00K |
| Cash Acquisitions | -- | -203.34M | -203.34M | -203.34M | -203.34M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -207.00K | -207.00K | -207.00K | 53.00K | 255.00K |
| Cash from Investing | -10.13M | -216.37M | -215.51M | -212.90M | -213.09M |
| Total Debt Issued | 17.60M | 24.60M | 24.60M | 23.15M | 23.69M |
| Total Debt Repaid | -26.60M | -24.59M | -24.59M | -1.47M | -1.47M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -29.85M | -29.87M | -29.85M | -14.65M | -12.67M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.75M | -1.26M | -379.00K | -- | -- |
| Cash from Financing | -40.60M | -31.13M | -30.23M | 7.03M | 9.55M |
| Foreign Exchange rate Adjustments | 5.11M | -3.61M | 1.67M | -1.67M | -6.19M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.27M | -219.59M | -181.05M | -148.74M | -148.74M |